Kusajili – Clinical trials directory

Result of your search per sponsor: Laboratorios Menarini S.A. - Menarini Group

Woman and Man Max 99 years
Laboratorios Menarini S.A. - Menarini Group Update Il y a 4 ans

DOUBLE-BLIND, RANDOMISED, PLACEBO-CONTROLLED, PARALLEL GROUP STUDY TO EVALUATE THE EFFECT OF A 4-WEEK TREATMENT WITH ORAL DOSES OF MEN15596 IN IRRITABLE BOWEL SYNDROME To evaluate the efficacy of three doses of MEN 15596 on IBS symptoms relief as compared to placebo in a broad population of irritable bowel syndrome (IBS) patients following a 4 week oral treatment.

Country None
organs None
Specialty None

Closed trial

More information